ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Top 4 trends shaping the healthcare industry
By Leora Borgenicht bio
Before the healthcare industry can ambitiously transform to offer more accurate and personalized patient care, certain stepping stones must…
FDA Watch: Agency Approves New STD Screening Assay Applications
From - Laboratory Industry Report
The FDA broke new ground by clearing a pair of STD screening assays for detecting chlamydia and gonorrhea for use with extragenital specimens, specifically from the…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
Here's a summary of the key product launches from late April to late May, 2019…
Business Best Practices: The 5 Essential Components of a Marketing Plan
From - Laboratory Industry Report
Although there's no single formula for marketing a lab, there are five basic elements a marketing plan should include&…
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
The pace of diagnostic deal making picked up from the end of March through mid-April. Here's a quick overview of the activity and…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of…
FDA Watch: New Warning Letter May Signal Resurgence of LDT Enforcement Activity
From - Laboratory Industry Report
After a couple of years of dormancy, the FDA laboratory developed test (LDT) enforcement volcano stirred on…
Improved Accuracy of Point-of-Care HbA1c Tests May Expand Access to Testing
...
Already a member? Log in here
